정맥영양요법을 시행 중인 고중성지방혈증 환자에서 fish oil이 함유된 지방유제 투여 효과 분석
The Effect of an Intravenous Fat Emulsion Composed of Fish Oil on Hypertriglyceridemia Patients Receiving Total Parenteral Nutrition
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Intravenous fat emulsion (IVFE) in parenteral nutrition (PN) has an advantage of slipplying essential fatty acids with non-glucose based energy. However, it has been associated with the development of hypertriglyceridemia. The principal management of PN-dependent patients with hypertriglyceridemia is to withhold the IVFE until serum triglyceride (TG) level is normalized. This practice may predispose patients to the development of essential fatty acid deficiency. This study evaluated the effects of fish oil fatty acids on TG levels and liver toxicity in PN dependent hypertriglyceridemia patients. This study included patients who developed TG levels > 400 mg/dL with soybean oil emulsion and then fish oil emulsion in their PN from October 2010 to April 2012 at Seoul St. Mary’s Hospital. The study investigated the differences in TG, aspartate transaminase (AST), alanine transaminase (ALT) and total bilirubin (TB) before and after the regimen change, and evaluated the significance of the differences. A total of 10 patients (6 adults and 4 children) were included. After administration of fish oil IVFE, the average serum TG level was decreased from 451 mg/dL to 250 mg/dL, and this was statistically significanthly different (P=0.006). The average serum AST was increased from 40.5 IU/L to 54.0 IU/L (P=0.910), but the average serum ALT was decreased from 33.5 IU/L to 26.5 IU/L (P=0.508). The average serum TB was increased from 0.7 mg/dL to 0.9 mg/dL (P=0.432). These results showed no statistically significant differences. In conclusion, this study suggests that PN with fish oil emulsion may result in an effective decrease in TG levels. Changes in the liver somatic index did not show statistically significant results. Therefore, we can presume that increased risk of hepatotoxicity did not occur. In order to achieve more accurate and reliable results, it is necessary to conduct randomized controlled trials for evaluating hepatotoxicity of fish oil fatty acids.
Abstract
Intravenous fat emulsion (IVFE) in parenteral nutrition (PN) has an advantage of slipplying essential fatty acids with non-glucose based energy. However, it has been associated with the development of hypertriglyceridemia. The principal management of PN-dependent patients with hypertriglyceridemia is to withhold the IVFE until serum triglyceride (TG) level is normalized. This practice may predispose patients to the development of essential fatty acid deficiency. This study evaluated the effects of fish oil fatty acids on TG levels and liver toxicity in PN dependent hypertriglyceridemia patients. This study included patients who developed TG levels > 400 mg/dL with soybean oil emulsion and then fish oil emulsion in their PN from October 2010 to April 2012 at Seoul St. Mary’s Hospital. The study investigated the differences in TG, aspartate transaminase (AST), alanine transaminase (ALT) and total bilirubin (TB) before and after the regimen change, and evaluated the significance of the differences. A total of 10 patients (6 adults and 4 children) were included. After administration of fish oil IVFE, the average serum TG level was decreased from 451 mg/dL to 250 mg/dL, and this was statistically significanthly different (P=0.006). The average serum AST was increased from 40.5 IU/L to 54.0 IU/L (P=0.910), but the average serum ALT was decreased from 33.5 IU/L to 26.5 IU/L (P=0.508). The average serum TB was increased from 0.7 mg/dL to 0.9 mg/dL (P=0.432). These results showed no statistically significant differences. In conclusion, this study suggests that PN with fish oil emulsion may result in an effective decrease in TG levels. Changes in the liver somatic index did not show statistically significant results. Therefore, we can presume that increased risk of hepatotoxicity did not occur. In order to achieve more accurate and reliable results, it is necessary to conduct randomized controlled trials for evaluating hepatotoxicity of fish oil fatty acids.
참고문헌 (21)
- Dan L. Waitzberg, "New parenteral lipid emulsion for clinical use", J Parenteral Enteral Nutr, 30(4), pp.351~367 (2006)
- Llop J., "The importance of clinical factors in parenteral nutirition associated hypertriglyceridemia", Clin Nutr, 22, pp.577~583 (2003)
- Chait A., "Severe hypertriglyceridemia : role of familial and acquired disorders", Metabolism, 32, pp.209~214 (1983)
- Maria Luisa Forchielli, "Nutritional goals and requirements", The A.S.P.E.N. Nutrition support practice manual 2ndedition, 114~115 (2005)
- Kathleen Gura, "The role of an intravenous fat emulsion composed of fish oil in parenteral nutrition dependent patient with hypertriglyceridemia", Clin Nutr, 22(6), pp.664~672 (2007)
- Freund H.R., "Abnormalities of liver function and hepatic damage associated with total parenteral nutrition", Nutrition, 7(1), pp.1~5 (1991)
- Clayton P.T., "Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease", Gastroenterology, 105(6) (1993)
- Socha P., "Essential fatty acid status in children with cholestasis in relation to serum bilirubin concentration", J pediatric, 131(5), pp.700~706 (1997)
- K.M. Gura, "Safety and efficacy of a fish oil based fat emulsion in the treatment of parenteral nutrition associated liver disease", Pediatircs, 23(4), pp.445~446 (2008)
- Kristine L., "Improving malnutrition documentation enhances reimbursement", J Am diet Assoc, 95(4), pp.468~475 (1995)
- Maria Luisa Forchielli, "Nutritional goals and requirements", The A.S.P.E.N. Nutrition support practice manual 2ndedition, 41~47 (2005)
- Pierre Singer, "ESPEN guidelines on parenteral nutrition : Intensive care", Clinical nutrition, 28, pp.387~400 (2009)
- Maria Luisa Forchielli, "Nutritional goals and requirements", The A.S.P.E.N. Nutrition support practice manual 2ndedition, 109~110 (2005)
- Cheng-Jen Ma, "A double blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical castrointestinal tumor patients", Nutrition in clinical practice, 27(3), pp.410~415 (2012)
- Spear M.L., "Effect of heparin dose and infusion rate on lipid clearance and bilirubin binding in premature infants receiving intravenous fat emulsion", J Pediater, 112, pp.94~98 (1988)
- De Meijer V.E., "Parenteral fish oil monotherapy in the management of patients with parenteral nutrition associated liver disease", Arch surg, 145(6), pp.547~551 (2010)
- De Meijer V.E., "Fish oil based lipid emulsions Prevent and reverse parenteral nutrition associated liver disease: the boston experience", J Parenteral Enteral Nutr, 33(5), pp.541~547 (2010)
- De Meijer V.E., "Parenteral nutrition in the critically ill patients", N Engl J med, 362(1), pp.81~82 (2010)
- Vanessa J. Kumpf, "Parenteral nutrition associated liver disease in adult and pediatric patiensts", Clin Nutr, 21(3), pp.279~290 (2006)
- Quigley E.M.M., "Hepatobiliary complications of total parenteral nutrition", Gastroenterology, 104, pp.286~301 (1993)
- Yin Yi Han, "Effect of fish oil on inflammatory modulation in surgical intensive care unit Patients", Nutrition in clinical practice, 27(1), pp.91~98 (2012)